What we do

We are able to provide consultancy support at every stage of the clinical development program of your assets

Here are some examples of projects we have conducted through the lifecycle:

	Pre-clinical and Phase I – Early Price potential assessment – Landscaping of disease and payer environment – Due diligence and commercial opportunity exploration – ATC & DDD strategy development
	Phase II–Phase III – Payer evidence generation, validation and WTP – Value gap and value driver analysis – Qualitative pricing – Value message testing and value proposition development
	Phase III–Launch – Pricing and access strategy – Revenue scenario testing – Launch sequencing through international price referencing analytical tools and strategic considerations – Advisory boards to develop optimum launch strategy in target markets – Payer segmentation and partnership development – Commercialisation strategy – Country specific market access understanding and strategies; including value based pricing in the US and UK
	Phase IV – Market dynamics with LoE and generic entry – Commercial optimisation and uptake – Navigating and mitigating Payer uncertainties with therapies and technologies